A Specific HPLC Method to Determine Residual HEPES in [(68)Ga]Ga-Radiopharmaceuticals: Development and Validation

Background: Nowadays, in Nuclear Medicine, clinically applied radiopharmaceuticals must meet quality release criteria such as high radiochemical purity and radiochemical yield. Many radiopharmaceuticals do not have marketing authorization and have no dedicated monograph within European Pharmacopeia...

Descripción completa

Detalles Bibliográficos
Autores principales: Migliari, Silvia, Scarlattei, Maura, Baldari, Giorgio, Silva, Claudia, Ruffini, Livia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323806/
https://www.ncbi.nlm.nih.gov/pubmed/35889351
http://dx.doi.org/10.3390/molecules27144477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323806/
https://www.ncbi.nlm.nih.gov/pubmed/35889351
http://dx.doi.org/10.3390/molecules27144477

Ejemplares similares